Temporary ex vivo inhibition of the expression of the human oncogene HER2 (NEU) by a triple helix-forming oligonucleotide. - Porumb,H.; Gousset,H.; Letellier,R.; Salle,V.; Briane,D.; Vassy,J.; Amor-Gueret,M.; Israel,L.; Taillandier,E. (Cancer Res, 1996)